5LK-62555-82415
2 vaccinations
2 coded responses
10 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 140 / NY
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Registered in v-safe
- 2021-02-20
-
2021-02-23
Dose 2 — Pfizer-BioNTech
- 2021-02-26
-
2021-02-27
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Good · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-28
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-08
- 2021-05-25
-
2021-08-24
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: Still pregnantMedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-23 | Pfizer-BioNTech |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): No
Release 9 — 6 months, dose 2
Symptoms: Still pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release